Grandhope Plans Filing For Approval Of Artificial Cornea
This article was originally published in PharmAsia News
Executive Summary
Grandhope Biotech has said that it has completed more than 30 artificial cornea procedures in its clinical trials for the product. The Chinese firm plans to carry out 72 operations as part of the program and to apply for regulatory approval by the end of June 2015.